Literature DB >> 4005139

A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer.

N Armitage, J D Hardcastle, S S Amar, T W Balfour, J Haynes, P D James.   

Abstract

Two faecal occult blood tests, a simple chemical test Haemoccult and an immunological test, Fecatwin Sensitive/Feca EIA, were offered to 3,225 asymptomatic individuals as screening for colorectal cancer. One thousand three hundred and four (44%) completed and returned the tests and of these 126 (9.7%) were found to be positive - Haemoccult 40 (3%) and Feca EIA 106 (8.1%). Five cancers (4 Dukes' Stage A, 1 Dukes' Stage C) and 23 adenomas greater than 1 cm were detected - rates of 3.8 per 1000 persons screened and 17.7 per 1000 persons screened respectively. Of the five cancers identified 5 were Feca EIA positive and 3 were Haemoccult positive. Of the 23 adenomas greater than 1 cm diameter identified, J1 were Feca EIA positive and 20 were Haemoccult positive. Seventy-eight Feca EIA positive subjects were investigated and no neoplastic disease was identified. Whilst this sensitive immunological test increases the yield of carcinomas, the high false positive rate makes it unsuitable for population screening for colorectal cancer in its present form.

Entities:  

Mesh:

Year:  1985        PMID: 4005139      PMCID: PMC1977091          DOI: 10.1038/bjc.1985.124

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Sensitivity and reproducibility of chemical tests for fecal occult blood with an emphasis on false-positive reactions.

Authors:  J D Ostrow; C A Mulvaney; J R Hansell; R S Rhodes
Journal:  Am J Dig Dis       Date:  1973-11

2.  An immunofluorescent test for faecal occult blood.

Authors:  K D Vellacott; R W Baldwin; J D Hardcastle
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

3.  Accuracy of occult blood tests over a six-day period.

Authors:  P A Farrands; J D Hardcastle
Journal:  Clin Oncol       Date:  1983-09

4.  Optimal dietary conditions for hemoccult testing.

Authors:  F A Macrae; D J St John; P Caligiore; L S Taylor; J W Legge
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

5.  [Occult blood in feces--a prospective study for the comparison of Hemoccult and Fecatest].

Authors:  K R Beretta; R Güller; M Singeisen; G A Stalder
Journal:  Schweiz Med Wochenschr       Date:  1978-12-02

6.  Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.

Authors:  F A Macrae; D J St John
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

7.  Evaluation of an immunological test for occult bleeding from colorectal neoplasia.

Authors:  J A Williams; R Hunter; M Smith; M E Coles; T W Hubert; D W Thomas
Journal:  Aust N Z J Surg       Date:  1982-12

8.  Immunochemical detection of human blood in feces.

Authors:  G H Barrows; R M Burton; D D Jarrett; G G Russell; M D Alford; C L Songster
Journal:  Am J Clin Pathol       Date:  1978-03       Impact factor: 2.493

9.  Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia.

Authors:  S J Winawer; M Andrews; B Flehinger; P Sherlock; D Schottenfeld; D G Miller
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

10.  Immunological detection of faecal occult blood in colorectal cancer.

Authors:  M J Turunen; K Liewendahl; P Partanen; H Adlercreutz
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

View more
  12 in total

1.  Is there a preference for different ways of performing faecal occult blood tests?

Authors:  J D Kettner; C Whatrup; J E Verne; K Young; C B Williams; J M Northover
Journal:  Int J Colorectal Dis       Date:  1990-05       Impact factor: 2.571

2.  Symposium: Screening for colorectal cancer.

Authors:  F Macrae; G Ekelund; B P Robra; R Gnauck; H Ribet; J Escourrou; J H Bond; N C Armitage; J B Simon
Journal:  Int J Colorectal Dis       Date:  1986-04       Impact factor: 2.571

3.  Faecal occult blood screening of first degree relatives of patients with colorectal cancer.

Authors:  N C Armitage; P A Farrands; C M Mangham; J D Hardcastle
Journal:  Int J Colorectal Dis       Date:  1986-10       Impact factor: 2.571

4.  Screening of colorectal tumours using an improved faecal occult blood test. Quantitative aspects.

Authors:  I Häkkinen; R Paasivuo; P Partanen
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

Review 5.  Colorectal carcinoma and Haemoccult. A study of its value in mass screening using meta-analysis.

Authors:  J Windeler; J Köbberling
Journal:  Int J Colorectal Dis       Date:  1987-11       Impact factor: 2.571

6.  Role of upper gastrointestinal investigations in a screening study for colorectal neoplasia.

Authors:  W M Thomas; J D Hardcastle
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

7.  Mass screening for colorectal cancer in Hungary.

Authors:  P Preisich; S Siba; E Szakátsy
Journal:  J R Soc Med       Date:  1987-06       Impact factor: 5.344

8.  Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme.

Authors:  R F Logan; J Little; P G Hawtin; J D Hardcastle
Journal:  BMJ       Date:  1993-07-31

Review 9.  Screening for colorectal cancer: a critical review.

Authors:  J D Hardcastle; G Pye
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

10.  Colorectal adenomas and diet: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme.

Authors:  J Little; R F Logan; P G Hawtin; J D Hardcastle; I D Turner
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.